Association of genomic polymorphisms of metabolising and DNA repair enzymes on clinical outcome of patients with advanced gastric cancer - results of a first interim analysis of a randomised multicenter phase II study comparing fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP)
2005 ◽
Vol 23
(16_suppl)
◽
pp. 2008-2008
Keyword(s):
Phase Ii
◽